Biogen Inc.
BIIB
$131.95
$3.953.09%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 163.95% | -9.82% | -31.35% | -33.43% | 48.35% |
| Total Depreciation and Amortization | 6.06% | -0.43% | 0.66% | 15.04% | 7.73% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -28.21% | -40.01% | 116.02% | 81.50% | -70.17% |
| Change in Net Operating Assets | -136.76% | -1,278.45% | -87.90% | 223.97% | 17.53% |
| Cash from Operations | -37.95% | -65.92% | -18.67% | 49.50% | 13.12% |
| Capital Expenditure | 28.30% | 5.60% | -12.29% | -4.48% | 27.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -198.04% | -149.28% | 129.03% | -114.26% | 2,587.56% |
| Cash from Investing | -20.51% | -154.30% | 98.43% | -353.18% | 806.82% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 37.50% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 121.30% | -391.14% | 219.70% | -237.50% | 112.12% |
| Cash from Financing | 49.13% | -391.14% | 219.70% | 97.31% | 44.22% |
| Foreign Exchange rate Adjustments | 99.13% | 146.10% | -275.47% | 436.51% | 45.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.12% | -66.96% | 422.27% | -125.13% | 3,306.12% |